Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

Robert J. Mayer, Roger B. Davis, Charles A. Schiffer et al. · New England Journal of Medicine · 1994 · 1.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia

R Zittoun, Franco Mandelli, Roel Willemze et al. · New England Journal of Medicine · 1995 · 854 citations · Full text

Medicine, Hematology, Oncology +14

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

George W. Santos, P. J. Tutschka, Ronald Brookmeyer et al. · New England Journal of Medicine · 1983 · 818 citations

Medicine, Hematology, Oncology +15

A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]

JF Bishop, JP Matthews, G. A. R. Young et al. · Blood · 1996 · 459 citations · Full text

Medicine, Oncology, Pharmacology +14

A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

Keith Wheatley, Alan K. Burnett, Anthony H. Goldstone et al. · British Journal of Haematology · 1999 · 435 citations

Medicine, Hematology, Oncology +14